Enoxaparin’s Effect on VTE and Major Bleeding After Bariatric Procedure
Investigators sought to determine the safety and efficacy of varying doses of enoxaparin regimens in patients receiving a bariatric procedure.
Investigators sought to determine the safety and efficacy of varying doses of enoxaparin regimens in patients receiving a bariatric procedure.
Higher levels of soluble urokinase plasminogen activator receptor linked to incident venous thromboembolism independently of D-dimer.
Researchers sought to determine whether there was a higher risk of developing thrombosis in patients with MPNs and COVID-19.
Abelacimab is a highly selective, fully human monoclonal antibody designed to inhibit both factor XI and its activated form, factor XIa.
A study was conducted to determine outcomes in hospitalized patients with COVID-19 and VTE, during anticoagulation therapy and at 1-year follow-up.
Researchers sought to determine the risk for pulmonary embolism, deep vein thrombosis, and bleeding in patients recovering from COVID-19 infection.
Rate ratios were highest for critical COVID-19, and during first versus second and third pandemic waves in Sweden.
Researchers sought to determine the predictors of mortality during hospital stays in patients with multiple myeloma.
Researchers sought to determine the risk factors for both venous and arterial thrombosis in neonates admitted to neonatal intensive care units.
Investigators compared outcomes of thrombolytic therapy and surgery as first-line treatment for patients with obstructive prosthetic valve thrombosis.